Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,137,301
-$129,356 QoQ
Shares Held
39,979
-8.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#1,033
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Alternative Capital holds $26,259,704 across 8 Drug Manufacturers - General names. MRK ranks #3 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,154 | $9,436,001 | |
| 2 | LLY |
ELI LILLY & Co
|
7,645 | $9,169,643 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
39,979 | $5,137,301 | |
| 4 | AMGN |
Amgen Inc
|
3,151 | $1,141,040 | |
| 5 | ABBV |
AbbVie Inc.
|
2,976 | $748,880 | |
| 6 | PFE |
Pfizer Inc
|
13,063 | $314,557 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,189 | $276,558 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
620 | $35,724 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,137,301 | 39,979 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,266,657 | 43,783 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,815,223 | 45,746 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,702,404 | 44,113 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,014,124 | 50,709 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $5,292,518 | 58,963 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $7,001,999 | 70,386 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $8,340,641 | 73,447 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,897,067 | 79,944 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $11,881,437 | 90,045 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,041,586 | 110,453 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,034,041 | 136,319 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $16,172,947 | 140,159 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $17,991,187 | 169,106 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $19,193,906 | 172,996 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $13,258,001 | 153,948 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $8,575,814 | 94,064 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $6,358,054 | 77,490 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $7,603,914 | 99,216 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,247,739 | 96,495 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $6,758,679 | 86,906 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $5,535,912 | 71,811 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,322,641 | 65,069 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,848,512 | 58,451 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $4,949,508 | 64,005 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $4,825,905 | 62,723 | Shares | Sole | 2020-06-09 | |
| No filing history on record for this holder in this stock. | ||||||